Bristol-Myers Squibb Co. (BMYD)
BCBA
Closed
Oct 5, 2026
Day's Range
20.4952 wk Range
0.00Overview - BMYD - Bristol-Myers Squibb Co.
Key Statistics
Valuation
Enterprise Value
77.43B
Price / Book
‪1.94‬
EV / EBITDA
‪4.09‬
Profitability
Profit Margin
‪18.87%‬
Operating Margin
‪34.41%‬
Return on Assets
‪10.71%‬
Return on Equity
‪46.59%‬
Ownership
Float
2.03B
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪0.22‬
50-Day Avg
‪21.62‬
200-Day Avg
‪19.66‬
Dividends
Frequency
Quarterly
Peers - BMYD - Bristol-Myers Squibb Co.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on BCBA.
- BMYDBCBABristol-Myers Squibb Co.+23.37%52-week change—P/E (Trailing)‪18.87%‬Profit Margin
- JNJBCBAJohnson & Johnson CEDEAR+38.30%52-week change11.00P/E (Trailing)‪21.48%‬Profit Margin
- GILDBCBAGilead Sciences Inc.+31.12%52-week change4.84P/E (Trailing)‪-10.63%‬Profit Margin
- MRKBCBAMerck & Co., Inc. CEDEAR+51.25%52-week change2.52P/E (Trailing)‪4.76%‬Profit Margin
- LLYBCBAEli Lilly and Company CEDEAR+43.62%52-week change0.19P/E (Trailing)‪33.52%‬Profit Margin
- BIIBBCBABiogen Inc. CEDEAR+43.89%52-week change3.32P/E (Trailing)‪8.32%‬Profit Margin
- AMGNBCBAAmgen Inc. Cedear+39.00%52-week change0.18P/E (Trailing)‪22.95%‬Profit Margin
Profile Summary - BMYD - Bristol-Myers Squibb Co.
About
Bristol-Myers Squibb Co. is a globally renowned biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines. With a strong focus on serious diseases, the company's primary purpose is to address unmet medical needs in oncology, cardiovascular, immunoscience, and fibrosis through…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
